Skip to main content
Other
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
(2011)
  • Kelly L. Sullivan, Georgia Southern University
Disciplines
Publication Date
2011
Citation Information
Kelly L. Sullivan (Sub-Investigator), "A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy," Allon Therapeutics, Inc. (2011-2012).